| Prospective, Randomized, Multinational, Multicenter, Double-blind, Placebo and Active Controlled Trial in 4 Parallel-groups of Patients Suffering From Seasonal Allergic Rhinitis (NCT05311475) | Sandoz | 2022-04-04 |
| Allergen Challenge Trial of IRL201104 in Seasonal Allergic Rhinitis (NCT05098522) | Revolo Biotherapeutics | 2021-11-04 |
| Acupuncture at the Sphenopalatine Ganglion in the Treatment of Moderate-to-severe Seasonal Allergic Rhinitis (NCT04815668) | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 2021-05-01 |
| To Investigate Drug-drug Interaction and Relative Bioavailability Between the FDC AzelastineHCL/Beclomethasone Dipropionate Nasal Spray, & Beclomethasone Dipropionate Nasal Spray in the Test Vehicle, and RinoClenil® Nasal Spray (NCT04817800) | Humanis Saglık Anonim Sirketi | 2021-03-25 |
| Biomarkers in Nasal Samples of Seasonal Allergic Rhinitics (NCT04670627) | University of North Carolina, Chapel Hill | 2021-03-22 |
| Dymista Allergen Chamber - Onset of Action Study (NCT04652245) | MEDA Pharma GmbH & Co. KG | 2020-12-14 |
| The Efficacy of Preseasonal Omalizumab Treatment (NCT04489121) | Beijing Tongren Hospital | 2020-07-28 |
| The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy (NCT04544774) | Universitaire Ziekenhuizen KU Leuven | 2020-07-16 |
| Efficacy, Safety and Underlying Mechanisms of Sphenopalatine Ganglion Acupuncture for Seasonal Allergic Rhinitis (NCT04052945) | Beijing Tongren Hospital | 2020-03-25 |
| Effectiveness of Sodium Hyaluronate In Relieving Nasal Symptoms Of Children With Seasonal Allergic Rhinitis (NCT04752956) | Saglik Bilimleri Universitesi | 2019-03-03 |
| A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients (NCT03570957) | Tanabe Pharma Corporation | 2018-07-17 |
| Evaluation of Nasal Inflammatory Biomarkers (NCT03450031) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2018-02-08 |
| Study of Efficacy and Safety of Omalizumab in Severe Japanese Cedar Pollinosis Adult and Adolescent Patients (NCT03369704) | Novartis Pharmaceuticals | 2017-12-15 |
| Effect and Underlying Immunological Mechanisms of Sublingual Immunotherapy in Allergic Rhinitis (NCT03649139) | Beijing Tongren Hospital | 2017-04-01 |
| A Study of Tolerability and Safety of a New Cumulative Dose of Grass MATA MPL (NCT03931993) | Allergy Therapeutics | 2017-01-16 |
| Effectiveness of Bifidobacteria in Children Affected by Seasonal Allergic Rhinitis (NCT02807064) | University of Campania Luigi Vanvitelli | 2016-12-01 |
| Non-interventional Study to Assess the Tolerability, the Safety Profile and the Adherence of Different Up-dosing Schemes for a Sublingual Immunotherapy Treatment (NCT03097432) | University Hospital of Cologne | 2016-10-20 |
| Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR) (NCT02631551) | Glenmark Specialty S.A. | 2016-03-01 |
| Psychological Factors That Influence Severity of Allergic Rhinitis (NCT04709614) | The University Clinic of Pulmonary and Allergic Diseases Golnik | 2016-01-01 |
| Dose Selection Study of Efficacy and Safety of Different Doses of Grass MATA MPL and Grass MATA Using mEECs™ (NCT02582073) | Allergy Therapeutics | 2015-11-07 |
| 4"S" - Seasonal Symptoms Suppression Study (NCT02557269) | Association Asthma, Bulgaria | 2015-05-01 |
| Allergen Biocube Study Evaluating Efficacy and Safety of Nasapaque Nasal Solution in Adult Subjects With Allergic Rhinitis (NCT02377895) | 3E Therapeutics Corporation | 2015-03-01 |
| Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204) (NCT02320396) | Organon and Co | 2015-01-09 |
| To Study GSP 301 in Patients With Seasonal Allergic Rhinitis (NCT02318303) | Glenmark Pharmaceuticals Ltd. India | 2014-12-01 |
| Efficacy and Safety of SPARC1310 in Seasonal Allergic Rhinitis (NCT01940146) | Sun Pharma Advanced Research Company Limited | 2014-10-01 |
| Study Immunology and Safety of 60-day Treatment of SQ Grass SLIT (Sublingual Immunotherapy)-Tablet in Adult Subjects With Grass Pollen-induced Allergic Rhinoconjunctivitis (NCT02245360) | Abbott | 2014-10-01 |
| Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™ (NCT02249663) | Teva Pharmaceuticals USA | 2014-08-01 |
| Comparative Safety and Efficacy of Two Steroid Treatments in the Relief of the Symptoms of Seasonal Allergic Rhinitis (NCT02230696) | Padagis LLC | 2014-08-01 |
| Compliance and Usability Study Evaluating RHINIX™ Nasal Filters (NCT02108379) | University of Aarhus | 2014-05-01 |
| Study of Grass-SPIRE in Subjects With Grass Allergies and Asthma (NCT02161107) | Circassia Limited | 2014-04-01 |
| Efficacy Park Study Assessing Rhinix™ Nasal Filters for Hay Fever (NCT02108574) | University of Aarhus | 2014-04-01 |
| Clinical Equivalence Study of Fluticasone Propionate Nasal Spray, 50 mcg/Actuation vs. Flonase in Allergic Rhinitis Patients (NCT02246920) | Teva Pharmaceuticals USA | 2014-03-01 |
| Efficacy and Safety of Fixed Dose Combination (FDC) of Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Molo; Also Referred as GSP 301) in the Treatment of Seasonal Allergic Rhinitis (SAR) (NCT03444506) | Glenmark Pharmaceuticals Ltd. India | 2014-01-27 |
| Safety Study of Ragweed-SPIRE in Subjects With Ragweed Allergies and Asthma (NCT02061670) | Circassia Limited | 2014-01-01 |
| Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis (NCT02125253) | Amneal Pharmaceuticals, LLC | 2014-01-01 |
| Evaluating the Efficacy of Ragweed-SPIRE Following Exposure to Ragweed Allergen in an Environmental Exposure Chamber (NCT02061709) | Circassia Limited | 2014-01-01 |
| A Study Comparing the Bioequivalence of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Apotex, Inc.) to That of Dymista™ Nasal Spray (Meda Pharmaceuticals, Inc.) in the Treatment of Seasonal Allergic Rhinitis (NCT02279563) | Apotex Inc. | 2013-12-01 |
| Monocenter 6-period Study in Patients With Seasonal Allergic Rhinitis to Birch Pollen to Establish a Challenge Model With Natural Birch Pollen in an Environmental Challenge Chamber (ECC) (NCT01983865) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2013-11-01 |
| Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR) (NCT01915823) | Meda Pharmaceuticals | 2013-07-01 |
| Study of the Efficacy and Safety of MK-0476 in Japanese Pediatric Participants With Seasonal Allergic Rhinitis (MK-0476-519) (NCT01857063) | Organon and Co | 2013-06-10 |
| Post Marketing Surveillance for Contac Bien Z in Japan (NCT02020902) | GlaxoSmithKline | 2013-03-01 |
| Clinical Equivalence Study of Mometasone Nasal Spray (NCT01850823) | Actavis Inc. | 2013-02-01 |
| Allergic Rhinitis Changes the Sinus Microbiome (NCT01852513) | University of Chicago | 2013-01-01 |
| Bepotastine Besilate Nasal Sprays in the Treatment of Seasonal Allergic Rhinitis (SAR) (NCT01753739) | Bausch & Lomb Incorporated | 2013-01-01 |
| Assessment of Fluticasone Propionate on Ocular Allergy Symptoms (NCT01817790) | GlaxoSmithKline | 2012-12-01 |
| Evaluation of the Beneficial Effects of a Nasal Spray of Resveratrol in Children With Seasonal Allergic Rhinitis (NCT02130440) | University of Campania Luigi Vanvitelli | 2012-11-01 |
| Phase II Study Evaluating ONO-4053 and Cetirizine in Subjects With Seasonal Allergic Rhinitis (NCT01748344) | Ono Pharmaceutical Co., Ltd. | 2012-11-01 |
| Combination Study Of S-555739/Cetirizine HCl In Adult Patients With Seasonal Allergic Rhinitis (NCT01651871) | Shionogi | 2012-07-01 |
| Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis (NCT01484119) | Idorsia Pharmaceuticals Ltd. | 2011-12-01 |
| A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR) (NCT01458275) | Sumitomo Pharma America, Inc. | 2011-11-01 |
| Retrospective Record Review of Adults and Children Advised for Allergen Immunotherapy (MK-7243-022) (NCT01549340) | ALK-Abelló A/S | 2011-11-01 |
| Effects of Phenylephrine Extended-Release Tablets on Allergy-Related Nasal Congestion (P08498 AM1) (NCT01413958) | Bayer | 2011-08-01 |
| Investigate the Safety/Tolerability and Efficacy of Bilastine 20mg in Korean Patients With Seasonal Allergic Rhinitis (NCT01400828) | Yuhan Corporation | 2011-06-01 |
| Immune-modulatory Effect of Probiotic Strain on Grass Pollen Allergic Individuals (NCT01660698) | Société des Produits Nestlé (SPN) | 2011-05-01 |
| Safety and Efficacy of Ectoin Allergy Nasal Spray and Ectoin Allergy Eye Drops in the Treatment of Seasonal Allergic Rhinitis (SAR) in Children and Adolescents (NCT01342601) | Bitop AG | 2011-04-01 |
| A Study Comparing The Bioequivalence Of Ciclesonide Nasal Spray (Apotex, Inc.) To That Of Omnaris™ Nasal Spray (Sepracor, Inc.) In The Treatment Of Seasonal Allergic Rhinitis (NCT02273817) | Apotex Inc. | 2011-03-01 |
| Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies (NCT01307319) | Teva Branded Pharmaceutical Products R&D, Inc. | 2011-03-01 |
| Trial of STAHIST in Seasonal Allergic Rhinitis (NCT01293201) | Magna Pharmaceuticals, Inc. | 2011-03-01 |
| Reduction of IgE Antibody in Human Allergic Subjects (NCT01280149) | Northwestern University | 2011-01-01 |
| Rhinitis, Cognition and Driving Performance (NCT01318681) | Maastricht University Medical Center | 2011-01-01 |
| Safety and Efficacy of Bepotastine Besilate Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (NCT01277341) | Bausch & Lomb Incorporated | 2010-12-01 |
| Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis (NCT01241214) | Idorsia Pharmaceuticals Ltd. | 2010-11-01 |
| Vienna Challenge Chamber Study Using RV658 in Subjects With Allergic Rhinitis (NCT01230619) | Respivert Ltd | 2010-10-01 |
| Prospective Observational Study of Concomitant Allergic Rhinitis Treatment Patterns Among Patients Starting on Fluticasone Furoate Nasal Spray in a Retail Pharmacy Setting (NCT01337323) | GlaxoSmithKline | 2010-09-01 |
| Clinical Trial of STAHIST in Seasonal Allergic Rhinitis (SAR) Subjects (NCT01171664) | Magna Pharmaceuticals, Inc. | 2010-09-01 |
| Vitamin D Plus Fluticasone Propionate (NCT01103934) | University of Chicago | 2010-06-01 |
| Safety, Pharmacokinetics, and Efficacy of Bepotastine Besilate Nasal Product After Ragweed Pollen Exposure in an Environmental Chamber (NCT01222299) | Bausch & Lomb Incorporated | 2010-05-01 |
| Eosinophil Markers and Development of Disease in Allergic Rhinitis (NCT01192386) | University of Aarhus | 2010-05-01 |
| Fluticasone Furoate Treatment of Daytime Somnolence and Cognitive Performance in Seasonal Allergic Rhinitis (NCT00997620) | Western Sky Medical Research | 2010-03-01 |
| A Single and Multiple Dose Study to Explore the Safety of JNJ-38224342 in Healthy Patients and Patients With Seasonal Allergies (NCT01054352) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2010-02-01 |
| Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR) (NCT01024608) | Teva Branded Pharmaceutical Products R&D, Inc. | 2009-12-31 |
| Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older (NCT01010971) | Sumitomo Pharma America, Inc. | 2009-12-01 |
| A Study to Determine the Capacity of VAK694 When Combined With Allergen Immunotherapy to Bring About Specific Immune Tolerance (NCT01018693) | Novartis Pharmaceuticals | 2009-11-01 |
| Effect of Veramyst and Olopatadine 0.2% Opthalmic Solution on Allergy Symptoms (NCT01007253) | University of Chicago | 2009-11-01 |
| AUTO-ACUSAR - Effects of Acupuncture on the Autonomic Nervous System in Seasonal Allergic Rhinitis Patients (NCT01271595) | Charite University, Berlin, Germany | 2009-08-01 |
| Consumer Preference Study of Two Formulations of Phenylephrine Hydrochloride (Study CL2008-15)(P07530)(COMPLETED) (NCT00976209) | Bayer | 2009-08-01 |
| The Effect of Nasal Carbon Dioxide (CO2) Used As-Needed in the Symptomatic Treatment of Seasonal Allergic Rhinitis (NCT00917020) | Capnia, Inc. | 2009-07-01 |
| The Effect of Nasal Carbon Dioxide (CO2) in the Symptomatic Treatment of Seasonal Allergic Rhinitis (NCT00917111) | Capnia, Inc. | 2009-07-01 |
| A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies (NCT00883168) | Meda Pharmaceuticals | 2009-04-01 |
| Comparison of Seasonal Allergic Rhinitis Treatment With 2 Antihistamines Used in Combination With Intranasal Corticosteroid (NCT00845195) | Alcon Research | 2009-03-01 |
| Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older With SAR (NCT00854360) | Teva Branded Pharmaceutical Products R&D, Inc. | 2009-03-01 |
| A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies (NCT00824473) | Meda Pharmaceuticals | 2008-12-01 |
| Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis (NCT00790023) | Sumitomo Pharma America, Inc. | 2008-11-01 |
| A Study to Compare the Efficacy of QAV680 Against Placebo in Treating Seasonal Allergic Rhinitis in an Environmental Exposure Chamber (NCT00784732) | Novartis | 2008-09-01 |
| A Study Evaluating the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies (NCT00740792) | Meda Pharmaceuticals | 2008-08-01 |
| The Effect of Nasal Carbon Dioxide (CO2) in the Treatment of Seasonal Allergic Rhinitis (NCT00688441) | Capnia, Inc. | 2008-07-01 |
| Study of the Effect of SCH 900538 on Congestion in Subjects With Seasonal Allergic Rhinitis (Study P05031)(COMPLETED) (NCT00673062) | Merck Sharp & Dohme LLC | 2008-05-01 |
| Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial (NCT00691665) | Alcon Research | 2008-05-01 |
| A Randomized, Double-blind, Placebo-controlled Study on the Effect of CVT-E002 in Patients With Seasonal Allergic Rhinitis (NCT00726401) | Afexa Life Sciences Inc | 2008-05-01 |
| A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis (NCT00653224) | UCB Pharma | 2008-04-01 |
| Acupuncture for Seasonal Allergic Rhinitis (NCT00610584) | Charite University, Berlin, Germany | 2008-04-01 |
| A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies (NCT00651118) | Meda Pharmaceuticals | 2008-03-01 |
| A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis (NCT00621959) | UCB Pharma | 2008-03-01 |
| Compare Captisol-Enabled (CE) Budesonide + Azelastine Nasal Solution and Rhinocort Aqua + Astelin in an Environmental Exposure Chamber (EEC) Study of Allergic Rhinitis (NCT00940953) | Ligand Pharmaceuticals | 2008-02-01 |
| MOA Study of Ze 339 in Seasonal Allergic Rhinitis (NCT00862225) | Max Zeller Soehne AG | 2008-01-01 |
| Safety and Efficacy Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis (P08648) (NCT00564421) | Merck Sharp & Dohme LLC | 2007-12-18 |
| Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR (NCT00574379) | Faes Farma, S.A. | 2007-12-01 |
| A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies (NCT00660829) | Meda Pharmaceuticals | 2007-12-01 |
| A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies (NCT00660517) | Meda Pharmaceuticals | 2007-12-01 |
| A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis (NCT00561717) | Bayer | 2007-10-01 |